229 related articles for article (PubMed ID: 24677287)
21. Hyaluronate tethered, "smart" multiwalled carbon nanotubes for tumor-targeted delivery of doxorubicin.
Datir SR; Das M; Singh RP; Jain S
Bioconjug Chem; 2012 Nov; 23(11):2201-13. PubMed ID: 23039830
[TBL] [Abstract][Full Text] [Related]
22. A multifunctional mesoporous silica nanocomposite for targeted delivery, controlled release of doxorubicin and bioimaging.
Xie M; Shi H; Li Z; Shen H; Ma K; Li B; Shen S; Jin Y
Colloids Surf B Biointerfaces; 2013 Oct; 110():138-47. PubMed ID: 23711784
[TBL] [Abstract][Full Text] [Related]
23. Temperature-triggered tumor-specific delivery of anticancer agents by cRGD-conjugated thermosensitive liposomes.
Kim MS; Lee DW; Park K; Park SJ; Choi EJ; Park ES; Kim HR
Colloids Surf B Biointerfaces; 2014 Apr; 116():17-25. PubMed ID: 24441178
[TBL] [Abstract][Full Text] [Related]
24. Natural gelatin capped mesoporous silica nanoparticles for intracellular acid-triggered drug delivery.
Zou Z; He D; He X; Wang K; Yang X; Qing Z; Zhou Q
Langmuir; 2013 Oct; 29(41):12804-10. PubMed ID: 24073830
[TBL] [Abstract][Full Text] [Related]
25. A dual location stimuli-responsive degradation strategy of block copolymer nanocarriers for accelerated release.
Chan N; Khorsand B; Aleksanian S; Oh JK
Chem Commun (Camb); 2013 Sep; 49(68):7534-6. PubMed ID: 23863915
[TBL] [Abstract][Full Text] [Related]
26. Anticancer activity of PEGylated matrix metalloproteinase cleavable peptide-conjugated adriamycin against malignant glioma cells.
Lim SH; Jeong YI; Moon KS; Ryu HH; Jin YH; Jin SG; Jung TY; Kim IY; Kang SS; Jung S
Int J Pharm; 2010 Mar; 387(1-2):209-14. PubMed ID: 19945519
[TBL] [Abstract][Full Text] [Related]
27. Fatty acyl amide derivatives of doxorubicin: synthesis and in vitro anticancer activities.
Chhikara BS; St Jean N; Mandal D; Kumar A; Parang K
Eur J Med Chem; 2011 Jun; 46(6):2037-42. PubMed ID: 21420207
[TBL] [Abstract][Full Text] [Related]
28. Transferrin-conjugated pluronic niosomes as a new drug delivery system for anticancer therapy.
Tavano L; Muzzalupo R; Mauro L; Pellegrino M; Andò S; Picci N
Langmuir; 2013 Oct; 29(41):12638-46. PubMed ID: 24040748
[TBL] [Abstract][Full Text] [Related]
29. Biodegradable ZnO@polymer core-shell nanocarriers: pH-triggered release of doxorubicin in vitro.
Zhang ZY; Xu YD; Ma YY; Qiu LL; Wang Y; Kong JL; Xiong HM
Angew Chem Int Ed Engl; 2013 Apr; 52(15):4127-31. PubMed ID: 23463695
[No Abstract] [Full Text] [Related]
30. Dendrimer-assisted formation of fluorescent nanogels for drug delivery and intracellular imaging.
Gonçalves M; Maciel D; Capelo D; Xiao S; Sun W; Shi X; Rodrigues J; Tomás H; Li Y
Biomacromolecules; 2014 Feb; 15(2):492-9. PubMed ID: 24432789
[TBL] [Abstract][Full Text] [Related]
31. Novel peptide conjugates for tumor-specific chemotherapy.
Langer M; Kratz F; Rothen-Rutishauser B; Wunderli-Allenspach H; Beck-Sickinger AG
J Med Chem; 2001 Apr; 44(9):1341-8. PubMed ID: 11311056
[TBL] [Abstract][Full Text] [Related]
32. Enantiomer-specific bioactivities of peptidomimetic analogues of mastoparan and mitoparan: characterization of inverso mastoparan as a highly efficient cell penetrating peptide.
Jones S; Howl J
Bioconjug Chem; 2012 Jan; 23(1):47-56. PubMed ID: 22148546
[TBL] [Abstract][Full Text] [Related]
33. Overcoming drug resistance by cell-penetrating peptide-mediated delivery of a doxorubicin dimer with high DNA-binding affinity.
Lelle M; Freidel C; Kaloyanova S; Tabujew I; Schramm A; Musheev M; Niehrs C; Müllen K; Peneva K
Eur J Med Chem; 2017 Apr; 130():336-345. PubMed ID: 28273560
[TBL] [Abstract][Full Text] [Related]
34. Vesicle-to-cytosol transport of disulfide-linked cargo mediated by an amphipathic cell-penetrating peptide.
Kenien R; Shen WC; Zaro JL
J Drug Target; 2012 Nov; 20(9):793-800. PubMed ID: 22994388
[TBL] [Abstract][Full Text] [Related]
35. PEG-doxorubicin conjugates: influence of polymer structure on drug release, in vitro cytotoxicity, biodistribution, and antitumor activity.
Veronese FM; Schiavon O; Pasut G; Mendichi R; Andersson L; Tsirk A; Ford J; Wu G; Kneller S; Davies J; Duncan R
Bioconjug Chem; 2005; 16(4):775-84. PubMed ID: 16029018
[TBL] [Abstract][Full Text] [Related]
36. Novel pH-sensitive charge-reversal cell penetrating peptide conjugated PEG-PLA micelles for docetaxel delivery: in vitro study.
Ouahab A; Cheraga N; Onoja V; Shen Y; Tu J
Int J Pharm; 2014 May; 466(1-2):233-45. PubMed ID: 24614579
[TBL] [Abstract][Full Text] [Related]
37. Dual-peptide-functionalized albumin-based nanoparticles with ph-dependent self-assembly behavior for drug delivery.
Chen B; He XY; Yi XQ; Zhuo RX; Cheng SX
ACS Appl Mater Interfaces; 2015 Jul; 7(28):15148-53. PubMed ID: 26168166
[TBL] [Abstract][Full Text] [Related]
38. Enhanced drug loading on magnetic nanoparticles by layer-by-layer assembly using drug conjugates: blood compatibility evaluation and targeted drug delivery in cancer cells.
Manju S; Sreenivasan K
Langmuir; 2011 Dec; 27(23):14489-96. PubMed ID: 21988497
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and biological activity of new arenediyne-linked isoxazolidines.
Romeo R; Navarra M; Giofrè SV; Carnovale C; Cirmi S; Lanza G; Chiacchio MA
Bioorg Med Chem; 2014 Jul; 22(13):3379-85. PubMed ID: 24835789
[TBL] [Abstract][Full Text] [Related]
40. Effect of Ala replacement with Aib in amphipathic cell-penetrating peptide on oligonucleotide delivery into cells.
Wada S; Hashimoto Y; Kawai Y; Miyata K; Tsuda H; Nakagawa O; Urata H
Bioorg Med Chem; 2013 Dec; 21(24):7669-73. PubMed ID: 24216093
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
